Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent Ppci

Familial Hypercoleresremia as Risk Factor in Stemi Patient Underwent Ppci

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03900169

Enrollment

Registered

2019-04-02

Start date

2020-11-01

Completion date

2021-11-01

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial Hypercholesterolemia

Brief summary

Famulial hypercolerstremia as risk factor

Detailed description

Familial hypercolerestremia ad risk factor in stemi patient who underwent Ppci

Interventions

GENETICGenetic

Lipid profile

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

-all patient that underwent Ppci

Exclusion criteria

* Previous ischemic patient * Patient with raised renal chemistry * Patient for CABG

Design outcomes

Primary

Measure	Time frame	Description
Correlation between familial hypercolerstremia and prognosis of patients in PPCI	One year	Correlation between familial hypercolerstremia and prognosis of patients in PPCI
Correlation between non familial hypercolerstremia and prognosis of patients in PPCI	One year	Correlation between non familial hypercolerstremia and prognosis of patients in PPCI

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026